Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-22-028761
Filing Date
2022-03-01
Accepted
2022-03-01 17:02:14
Documents
1
Period of Report
2022-02-25

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm227953-3_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm227953-3_4seq1.xml 4 3318
  Complete submission text file 0001104659-22-028761.txt   4628
Mailing Address 535 BOYLSTON STREET BOSTON MA 02116
Business Address 535 BOYLSTON STREET BOSTON MA 02116 6095104718
Aprea Therapeutics, Inc. (Issuer) CIK: 0001781983 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 535 BOYLSTON STREET BOSTON MA 02116
Business Address
Korbel Gregory Alan (Reporting) CIK: 0001789032 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39069 | Film No.: 22699379